IL-33 promotes type 1 cytokine expression via p38 MAPK in human NK cellsDavid E. Ochayon, Stephen N. Waggoner, Leah C. Kottyan et al.|Journal of Leukocyte Biology|2020Cited by 51
The Promise and Peril of Natural Killer Cell Therapies in Pulmonary InfectionSanjeeth Rajaram, Stephen N. Waggoner, Ayad Ali et al.|Immunity|2020Cited by 26
Immunomodulatory effects of cytokine-induced expansion of cytotoxic lymphocytes in a mouse model of lupus-like diseaseSeth D. Reighard, Stephen N. Waggoner, Hilal Cevik et al.|Cytotherapy|2020Cited by 3
Interleukin-33 promotes type 1 cytokine expression via p38 MAPK in human natural killer cellsDavid E. Ochayon, Stephen N. Waggoner, Pablo C. Alarcon et al.|bioRxiv (Cold Spring Harbor Laboratory)|2019Cited by 1
Immunomodulatory effects of cytokine-induced expansion of cytotoxic lymphocytes in a mouse model of lupus-like diseaseSeth D. Reighard, Stephen N. Waggoner, Hilal Cevik et al.|bioRxiv (Cold Spring Harbor Laboratory)|2019Cited by 1